- Home
- BBNX vs CDNA Comparison
BBNX vs CDNA Comparison
Compare BBNX & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBNX
- CDNA
- Stock Information
- Founded
- BBNX 2015
- CDNA 1998
- Country
- BBNX United States
- CDNA United States
- Employees
- BBNX N/A
- CDNA N/A
- Industry
- BBNX Medical/Dental Instruments
- CDNA Medical Specialities
- Sector
- BBNX Health Care
- CDNA Health Care
- Exchange
- BBNX Nasdaq
- CDNA Nasdaq
- Market Cap
- BBNX 740.7M
- CDNA 712.2M
- IPO Year
- BBNX 2025
- CDNA 2014
- Fundamental
- Price
- BBNX $26.41
- CDNA $13.53
- Analyst Decision
- BBNX Strong Buy
- CDNA Buy
- Analyst Count
- BBNX 10
- CDNA 8
- Target Price
- BBNX $24.40
- CDNA $26.86
- AVG Volume (30 Days)
- BBNX 690.5K
- CDNA 1.5M
- Earning Date
- BBNX 11-06-2025
- CDNA 11-03-2025
- Dividend Yield
- BBNX N/A
- CDNA N/A
- EPS Growth
- BBNX N/A
- CDNA N/A
- EPS
- BBNX N/A
- CDNA 1.00
- Revenue
- BBNX $69,830,000.00
- CDNA $340,826,000.00
- Revenue This Year
- BBNX $42.80
- CDNA $13.02
- Revenue Next Year
- BBNX $34.58
- CDNA $12.85
- P/E Ratio
- BBNX N/A
- CDNA $13.56
- Revenue Growth
- BBNX 38911.17
- CDNA 14.72
- 52 Week Low
- BBNX $8.89
- CDNA $10.96
- 52 Week High
- BBNX $26.66
- CDNA $32.97
- Technical
- Relative Strength Index (RSI)
- BBNX 85.28
- CDNA 52.36
- Support Level
- BBNX $18.12
- CDNA $13.12
- Resistance Level
- BBNX $19.32
- CDNA $13.80
- Average True Range (ATR)
- BBNX 1.35
- CDNA 0.67
- MACD
- BBNX 0.75
- CDNA 0.16
- Stochastic Oscillator
- BBNX 97.43
- CDNA 63.39
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.